Seger ME - Search Results

1

Effect of age on the pharmacokinetics of duloxetine in women.

Skinner MH, Kuan HY, Skerjanec A, Seger ME, Heathman M, O'Brien L, Reddy S, Knadler MP. Skinner MH, et al. Among authors: seger me. Br J Clin Pharmacol. 2004 Jan;57(1):54-61. doi: 10.1046/j.1365-2125.2003.01963.x. Br J Clin Pharmacol. 2004. PMID: 14678340 Free PMC article. Clinical Trial.

2

Bioequivalence and comparative pharmacodynamics of insulin lispro 200 U/mL relative to insulin lispro (Humalog®) 100 U/mL.

de la Peña A, Seger M, Soon D, Scott AJ, Reddy SR, Dobbins MA, Brown-Augsburger P, Linnebjerg H. de la Peña A, et al. Clin Pharmacol Drug Dev. 2016 Jan;5(1):69-75. doi: 10.1002/cpdd.221. Epub 2015 Oct 5. Clin Pharmacol Drug Dev. 2016. PMID: 27119580 Free PMC article. Clinical Trial.

3

Effect of exenatide on the pharmacokinetics of a combination oral contraceptive in healthy women: an open-label, randomised, crossover trial.

Kothare PA, Seger ME, Northrup J, Mace K, Mitchell MI, Linnebjerg H. Kothare PA, et al. Among authors: seger me. BMC Clin Pharmacol. 2012 Mar 19;12:8. doi: 10.1186/1472-6904-12-8. BMC Clin Pharmacol. 2012. PMID: 22429273 Free PMC article. Clinical Trial.

4

Exenatide - pharmacokinetics, pharmacodynamics, safety and tolerability in patients ≥ 75 years of age with Type 2 diabetes.

Linnebjerg H, Kothare PA, Seger M, Wolka AM, Mitchell MI. Linnebjerg H, et al. Int J Clin Pharmacol Ther. 2011 Feb;49(2):99-108. doi: 10.5414/cp201361. Int J Clin Pharmacol Ther. 2011. PMID: 21255526 Clinical Trial.

5

LY2963016 Insulin Glargine and Insulin Glargine (Lantus) Produce Comparable Pharmacokinetics and Pharmacodynamics at Two Dose Levels.

Zhang X, Lam ECQ, Seger ME, Coutant D, Chua L, Tan LH, Soon D, Linnebjerg H. Zhang X, et al. Among authors: seger me. Clin Pharmacol Drug Dev. 2017 Nov;6(6):556-563. doi: 10.1002/cpdd.392. Epub 2017 Sep 21. Clin Pharmacol Drug Dev. 2017. PMID: 28940840 Clinical Trial.

6

Pharmacokinetic-pharmacodynamic analysis of drotrecogin alfa (activated) in patients with severe sepsis.

Macias WL, Dhainaut JF, Yan SC, Helterbrand JD, Seger M, Johnson G 3rd, Small DS. Macias WL, et al. Clin Pharmacol Ther. 2002 Oct;72(4):391-402. doi: 10.1067/mcp.2002.128148. Clin Pharmacol Ther. 2002. PMID: 12386641 Clinical Trial.

7

QT effect of semagacestat at therapeutic and supratherapeutic doses.

Zhang W, Ayan-Oshodi M, Willis BA, Annes W, Hall SD, Chiesa J, Seger M. Zhang W, et al. Int J Clin Pharmacol Ther. 2012 Apr;50(4):290-9. doi: 10.5414/cp201672. Int J Clin Pharmacol Ther. 2012. PMID: 22456300 Clinical Trial.

8

Inhibition of PKC beta by ruboxistaurin does not enhance the acute blood pressure response to nitroglycerin.

Benson C, Seger M, Voelker J. Benson C, et al. Clin Pharmacol Ther. 2007 Aug;82(2):181-6. doi: 10.1038/sj.clpt.6100210. Epub 2007 Apr 18. Clin Pharmacol Ther. 2007. PMID: 17443133 Clinical Trial.

9

AIR insulin capsules of different dose strengths may be combined to yield equivalent pharmacokinetics and glucodynamics.

de la Peña A, Seger M, Rave K, Heinemann L, Silverman B, Muchmore DB. de la Peña A, et al. Diabetes Technol Ther. 2009 Sep;11 Suppl 2:S75-80. doi: 10.1089/dia.2009.0057. Diabetes Technol Ther. 2009. PMID: 19772452 Clinical Trial.

10

Pergolide: multiple-dose pharmacokinetics in patients with mild to moderate Parkinson disease.

Thalamas C, Rajman I, Kulisevsky J, Lledó A, Mackie AE, Blin O, Gillespie TA, Seger M, Rascol O. Thalamas C, et al. Clin Neuropharmacol. 2005 May-Jun;28(3):120-5. doi: 10.1097/01.wnf.0000168581.97083.9c. Clin Neuropharmacol. 2005. PMID: 15965310 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

19 results

Search Page

Filters